A high-throughput DNA sequencing technique called Next Generation Sequencing (NGS) separates billions or millions of DNA strands and sequences them simultaneously, producing more data and obviating the need for fragment-cloning techniques (Sanger sequencing of genomes). However, because the signal to noise ratio rises with read length, NGS read durations are shorter than Sanger. NGS enables for the simultaneous screening of many different genes for alterations. For instance, exome sequencing can be used by a patient with Leigh syndrome symptoms to identify potential gene variations. Additionally, it is utilised to analyse and analyse sequenced data, looking at a particular gene linked to the patient’s clinical state.
The global next generation sequencing market is estimated to be valued at US$ 12,870.5 million in 2023 and is expected to exhibit a CAGR of 18.3% during the forecast period (2023-2030).
Next Generation Sequencing Market Dynamics :
The Next Generation Sequencing (NGS) market is poised for significant growth due to its transformative impact on genomics research, clinical diagnostics, and personalized medicine. Advancements in technology have led to reduced costs, faster turnaround times, and higher throughput, democratizing genomic analysis. Increasing applications in oncology, rare disease identification, and infectious disease tracking drive demand. Collaboration between NGS companies and pharmaceutical firms for drug development and biomarker discovery further propels the market. Challenges include data management complexities, standardization concerns, and ethical considerations regarding data privacy. Overall, the NGS market is anticipated to experience substantial expansion as it continues to reshape healthcare and life sciences.
Ask Us to Get Your Sample Copy Of The Report, Covering TOC and Regional Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/158
Next Generation Sequencing Market Drivers :
The Next Generation Sequencing (NGS) market is driven by rapid technological advancements, enabling higher accuracy, throughput, and reduced costs. NGS’s pivotal role in precision medicine, clinical diagnostics, and drug development fuels its growth. Rising prevalence of genetic disorders, cancer, and infectious diseases amplifies demand for NGS-based solutions. Collaborations between NGS companies and research institutions foster innovation. The expanding applications in agrigenomics and metagenomics also contribute to market expansion. Moreover, increasing government and private funding for genomics research and healthcare infrastructure development play a vital role in driving the NGS market forward.
Next Generation Sequencing Market Trends and Restraints :
Trends:
- Clinical Integration: Next Generation Sequencing (NGS) is rapidly integrating into clinical settings, enabling personalized treatment plans and early disease detection.
- Single-Cell Sequencing: Advancements in single-cell sequencing technologies facilitate a deeper understanding of cellular heterogeneity and complex biological processes.
- Liquid Biopsies: NGS-based liquid biopsies are gaining traction for non-invasive cancer monitoring and early detection, revolutionizing oncology diagnostics.
- AI and Data Analytics: The marriage of NGS with artificial intelligence enhances data analysis, interpretation, and predictive modeling, unlocking deeper insights from genomic data.
- Long-Read Sequencing: Long-read NGS technologies address complex genomic regions, uncover structural variations, and aid in assembling genomes with higher accuracy.
Restraints:
- Data Management: The sheer volume of NGS data strains data storage, management, and analysis pipelines, demanding robust infrastructure and solutions.
- Standardization: Lack of standardized protocols and quality control measures across NGS platforms can hinder reproducibility and comparability of results.
- Ethical Concerns: Privacy issues arise due to the sensitive nature of genomic data, necessitating careful handling, consent procedures, and regulatory compliance.
- Cost Barriers: While costs have decreased, NGS still requires significant investment in equipment, reagents, and skilled personnel, limiting accessibility in certain regions.
- Bioinformatics Challenges: Complex bioinformatics analysis demands expertise, hindering adoption in clinical settings and necessitating user-friendly tools.
Next Generation Sequencing Market Regional Insights :
The Next Generation Sequencing (NGS) market exhibits regional diversity. North America leads with its robust research infrastructure, substantial investments, and adoption in clinical applications. Europe follows suit, driven by genomics initiatives and collaborations. The Asia-Pacific region showcases rapid growth due to expanding healthcare facilities and increasing research endeavors. Emerging economies like China and India contribute significantly to the market. Meanwhile, Latin America and the Middle East observe a gradual uptake of NGS technologies, often driven by partnerships with global players. Regional disparities in regulatory frameworks, reimbursement policies, and infrastructure development influence NGS adoption rates across the globe.
Global Next Generation Sequencing: Key Developments
In June 6, 2022, PerkinElmer, Inc., a global corporation focused in the business areas of diagnostics, life science research, food, environmental and industrial testing, announced the launch of the research use only (RUO) BioQule NGS System , an automated benchtop solution for next-generation sequencing (NGS) library preparation of up to eight samples. By incorporating automated thermocycling, integrated quality control through optical quantification and robust liquid handling technology into a single device, the BioQule NGS System enables researchers to produce high quality NGS libraries that yield reliable, reproducible results in a variety of applications requiring genomic analysis
In May, 2022, NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced a seamless, cloud-based workflow that improves the spatial data analysis experience of customers using Illumina NextSeq 1000 and NextSeq 2000 sequencing systems and the GeoMx Digital Spatial Profiler. The spatial analysis of whole transcriptomes combined with proteome analytes can now be simplified using this integrated, push-button run planning tool.
Key Players
Major players operating in the global next generation sequencing market include Thermo Fisher Scientific Inc., Agilent Technologies, Inc, bioMérieux SA, F. Hoffmann-La Roche Ltd , QIAGEN, Illumina, Inc., Oxford Nanopore Technologies plc., BGI, PerkinElmer Genomics, and Pierian
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐔𝐩 𝐓𝐨 𝟐𝟓% 𝐎𝐅𝐅 @ https://www.coherentmarketinsights.com/insight/buy-now/158
| The market size value in 2023 |
Table of Contents with Major Points:
Executive Summary
- Introduction
- Key Findings
- Recommendations
- Definitions and Assumptions
Executive Summary
Market Overview
- Definition of Next Generation Sequencing Market
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Trends and Developments
Key Insights
- Key Emerging Trends
- Key Developments Mergers and Acquisition
- New Product Launches and Collaboration
- Partnership and Joint Venture
- Latest Technological Advancements
- Insights on Regulatory Scenario
- Porters Five Forces Analysis
Qualitative Insights Impact of COVID-19 on Global Next Generation Sequencing Market
- Supply Chain Challenges
- Steps taken by Government/Companies to overcome this impact
- Potential opportunities due to COVID-19 outbreak
Conclusion
Appendix
- Data Sources
- Abbreviations
- Disclaimer
TOC Continued…!
Why Choose Coherent Market Insights?
☛ Identified business opportunities – Our market research report can be used to analyze potential markets and new products. It can give information about customer needs, preferences, and attitudes. Also, it compare products and services.
☛ A clear understanding of your customers – A market report gives company’s marketing department an in-depth picture about customers’ needs and wants. This knowledge can be used to improve products, prices, and advertising.
☛ Clear data-driven insights – Our Market research encompasses a wide range of activities, from determining market size and segment to forecasting demand, and from identifying competitors to monitoring pricing. All of these are quantified and measurable which means that gives you a clear path for building unique decisions based on numbers.
Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/158
Explore More Related Insights:
- Oligonucleotide Synthesis Market
- Softgel Capsule Market
- North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market
- Automated Patch Clamp System Market
- Coronavirus Treatment Drugs Market
- Pyrazinamide Market
- Platelet Concentration Systems Market
- Seasonal Affective Disorder Market
- Tissue and Organ Transplantation Market
- India Orthopedic Braces & Support, Casting & Splints Market
- Vascular Patches Market
- MENA Biologics & Biosimilars Market
- Alagille Syndrome Treatment Market
- U.K. Medical Pendant Market
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Mr Shah
Coherent Market Insights
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837